Have a Claim?

Click here for a confidential contact or call:

1-212-350-2774

Whistleblower Case

This archive displays posts tagged as involving a whistleblower case or claim. You may also be interested in our pages:

Page 59 of 111

March 13, 2018

Marshfield Medical, Inc. (formerly known as Bromedicon, Inc.) agreed to pay $550,000 to settle claims it violated the False Claims Act for submitting claims to Medicare and other federal health care programs without providing a qualified interpreting physician to monitor each surgery for which it purportedly provided remote Intraoperative Neurophysiological Monitoring. According to the government, in some of those cases, no one monitored the data stream from the surgeries and in others, Bromedicon’s medical director, a foreign medical school graduate with no license to practice medicine in the United States, was the only monitor. The allegations originated in a whistleblower lawsuit filed under the qui tam provisions of the False Claims Act.  DOJ (EDPA)

March 12, 2018

Virginia-based trucking company Beam Bros. Trucking Inc. and its principals Gerald and Garland Beam agreed to pay roughly $1 million to resolve allegations they violated the False Claims Act through the company's overcharging the U.S. Postal Service on contracts to transport mail. According to the government, Beam Bros. misused government Voyager Cards, provided by USPS to purchase fuel, to purchase fuel on contracts that did not allow for their use, resulting in inflated charges. The allegations originated in a whistleblower lawsuit filed under the qui tam provisions of the False Claims Act by former Beam Bros. employee Bobby Blizzard. He will receive a yet-to-be-determined whistleblower award from the proceeds of the government's recovery. DOJ

March 8, 2018

Kmart Corporation agreed to pay $525,000 to settle claims it violated the False Claims Act by submitting claims for reimbursement to California’s Medi‑Cal program that were not supported by applicable diagnosis and documentation requirements. The allegations originated in a whistleblower lawsuit filed under the qui tam provisions of the False Claims Act by a Kmart pharmacist. The whistleblower will receive a whistleblower award of roughly $96,500 from the proceeds of the government’s recovery. DOJ (EDCA)

March 8, 2018

Genetic testing company Natera, Inc. agreed to pay roughly $11.4 million to settle claims it violated the False Claims Act by improperly billing federal healthcare programs for Natera’s non-invasive prenatal test known as Panorama. The allegations originated in a whistleblower lawsuit filed under the qui tam provisions of the False Claims Act by Sallie McAdoo and Steven Aldridge. They will receive a yet-to-be-determined whistleblower award from the proceeds of the government’s recovery. DOJ (WDKY)

March 8, 2018

Massachusett’s-based Abiomed, Inc. agreed to pay $3.1 million to settle claims of violating the False Claims Act and Anti-Kickback Statute by purchasing lavish meals for physicians in order to induce them to use Abiomed’s Impella line of heart pumps. The allegations originated in a whistleblower lawsuit filed under the qui tam provisions of the False Claims Act by a former Abiomed employee. The whistleblower will receive an award of $542,500 from the proceeds of the government’s recovery. DOJ (MA)

March 7, 2018

UPMC Hamot, affiliated with the University of Pittsburgh Medical Center, and Medicor Associates Inc., a regional physician cardiology practice, agreed to pay $20.7 million to settle charges of violating the False Claims Act, Anti‑Kickback Statute and Stark Law through Hamot's payment under twelve physician and administrative services arrangements to secure Medicor patient referrals. Hamot allegedly had no legitimate need for the services contracted for, and in some instances the services either were duplicative or were not performed. The allegations originated in a whistleblower lawsuit filed under the qui tam provisions of the False Claims Act by former Medicor employee Dr. Tullio Emanuele. He will receive a whistleblower award of roughly $6 million from the proceeds of the government's recovery. DOJ

March 7, 2018

Florida dermatologist and owner of Treasure Coast Dermatology agreed to pay $2.5 million to settle claims he violated the False Claims Act by billing Medicare and TRICARE for procedures he did not perform.  The allegations originated in a whistleblower lawsuit filed under the qui tam provisions of the False Claims Act by Patricia Cleary, a former patient of Dr. Ioannides. She will receive a whistleblower award of $475,000 from the proceeds of the government’s recovery. DOJ (SDFL)

February 26, 2018

Brattleboro Memorial Hospital, Inc. paid $1,655,000 to settle claims it violated the False Claims Act by submitting outpatient laboratory claims lacking documentation necessary to support reimbursement by Medicare and Medicaid. The allegations originated in a whistleblower lawsuit filed under the qui tam provisions of the False Claims Act by Amy Beth Main. She will receive a whistleblower award from the proceeds of the government’s recovery. DOJ (VT)

February 13, 2018

British Knitwear Retailer Pure Collection Ltd. and its CEO Samantha Harrison agreed to pay $908,100 to resolve allegations they violated the False Claims Act by avoiding U.S. customs duties owed on merchandise shipped from the United Kingdom to U.S. customers, including many customers in Maine. According to the government, they did so by breaking up single shipments into multiple shipments of lesser value in order to avoid the applicable duties. The allegations originated in a whistleblower lawsuit filed under the qui tam provisions of the False Claims Act by Andrew Patrick. He will receive a yet-to-be determined award from the proceeds of the government’s recovery. DOJ (D. ME)

February 8, 2018

Privately owned for-profit hospice company Horizons Hospice, LLC and its owner agreed to pay roughly $1.2 million to settle claims they violated the False Claims Act for billing Medicare and Medicaid for hospice services for patients who were ineligible for hospice. The allegations originated in two whistleblower lawsuits filed under the qui tam provisions of the False Claims Act.  DOJ (WDPA)
1 57 58 59 60 61 111